Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2012
12/20/2012WO2012126123A8 Method of recovering plant-derived proteins
12/20/2012WO2012125005A3 Pol i promoter derived from vero cells and recombinant vector containing same
12/20/2012WO2012115493A3 Biomarker for cancer, and cancer diagnosis using same
12/20/2012WO2012115464A3 Composition for hot-start pcr comprising blocking oligonucleotide
12/20/2012WO2012115454A3 Method for concentrating cells that are genetically altered by nucleases
12/20/2012WO2012112012A3 Simultaneous diagnosis kit for a disease due to a respiratory virus
12/20/2012WO2012108706A3 Kit for diagnosing tamiflu-sensitive and resistant novel influenza a (h1n1) simultaneously and diagnosis method using same
12/20/2012WO2012108675A3 Pna aptamer able to isolate a metal
12/20/2012WO2012108672A3 Reverse transcriptase having improved thermostability
12/20/2012WO2012108669A3 Uranyl ion specific dna aptamer
12/20/2012WO2012102584A3 Sensor for detecting target virus, and method for screening target virus and analyzing mutation location using same
12/20/2012WO2012088461A3 Linker peptides and polypeptides comprising same
12/20/2012WO2012065043A9 Classification of nucleic acid templates
12/20/2012WO2012024659A9 Antibody-based constructs directed against tyrosine kinase receptors
12/20/2012WO2011154420A3 Tear lipocalin muteins binding il-4 r alpha
12/20/2012WO2011138040A8 Vaccine against beta-herpesvirus infection and use thereof
12/20/2012WO2009013324A9 Vector particles for targeting cd34+ cells
12/20/2012US20120324603 Chimeric Endonucleases and Uses Thereof
12/20/2012US20120324600 Constitutive synthetic plant promoters and methods of use
12/20/2012US20120324599 Methods and Compositions for Gray Leaf Spot Resistance in Corn
12/20/2012US20120324596 Broccoli hybrid px 05181808 and parents thereof
12/20/2012US20120324595 Cucumber hybrid ps 14741865 and parents thereof
12/20/2012US20120324594 Pea line ex08240782
12/20/2012US20120322992 Polynucleotide encoding acyl-coa synthetase homolog and use thereof
12/20/2012US20120322982 Anti-vegf antibodies
12/20/2012US20120322865 Sustained polypeptide expression from synthetic, modified rnas and uses thereof
12/20/2012US20120322860 Aptamer therapeutics useful in the treatment of complement-related disorders
12/20/2012US20120322858 Compositions and Methods for Inhibiting Expression of a Mutant Gene
12/20/2012US20120322857 Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells
12/20/2012US20120322856 Method for Promoting Angiogenesis, Vascularization, or Vessel Repair or for the Inhibiting Tumor Angiogenesis
12/20/2012US20120322855 Duplex Oligonucleotide Complexes and Methods for Gene Silencing by RNA Interference
12/20/2012US20120322852 SMNdelta7 Degron: Novel Compositions and Methods of Use
12/20/2012US20120322850 Trpm-2 antisense therapy
12/20/2012US20120322848 Lna oligonucleotides and the treatment of cancer
12/20/2012US20120322847 ANTISENSE ANTIVIRAL COMPOUND AND METHOD FOR TREATING ssRNA VIRAL INFECTION
12/20/2012US20120322846 METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF SINGLE AND DOUBLE BLUNT-ENDED siRNA
12/20/2012US20120322744 Poly-pegylated protease inhibitors
12/20/2012US20120322739 Albumin Variants
12/20/2012US20120322735 Modified growth hormone polypeptides
12/20/2012US20120322689 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
12/20/2012US20120322684 G-csf protein having a deletion of an amino acid sequence corresponding to exon 3 for use as a diagnostic cancer marker
12/20/2012US20120322678 Novel phage display vector
12/20/2012US20120322674 Detecting cyp24 expression level as a marker for predisposition to cancer
12/20/2012US20120322660 Down-regulating gene expression in insect pests
12/20/2012US20120322157 Stress-induced lipid trigger
12/20/2012US20120322156 Membrane fusion proteins derived from reovirus
12/20/2012US20120322148 Novel Ecdysone Receptor-Based Inducible Gene Expression System
12/20/2012US20120322146 Neural cell populations from primate pluripotent stem cells
12/20/2012US20120322136 Polynucleotides encoding recombinant ketoreductase polypeptides
12/20/2012US20120322122 Compositions and methods for improved plant feedstock
12/20/2012US20120322116 Method for transforming stramenopiles
12/20/2012US20120322112 Crude biological derivatives competent for nucleic acid detection
12/20/2012US20120322109 Covalent Joining of DNA Strands to RNA Strands Catalyzed by Vaccinia Topoisomerase
12/20/2012US20120322106 Production of Cellulases and Hemicellulases in Algal Biofuel Feedstocks
12/20/2012US20120322105 Growth factor
12/20/2012US20120322104 Systems and methods for protein production
12/20/2012US20120322102 Genetically engineered herbicide resistant algae
12/20/2012US20120322100 Methods for producing modified glycoproteins
12/20/2012US20120322095 Novel 2,5-Diketo-L-Gluconic Acid Reductases and Methods Of Use
12/20/2012US20120322083 Antibody binding to abca1 polypeptide
12/20/2012US20120322078 Production of Propanols, Alcohols, and Polyols in Consolidated Bioprocessing Organisms
12/20/2012US20120322059 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection
12/20/2012US20120322057 Polymerase compositions and methods
12/20/2012US20120322056 Rna-exit-channel: target and method for inhibition of bacterial rna polymerase
12/20/2012US20120322036 Computer-assisted means for assessing lifestyle risk factors
12/20/2012US20120321747 Proteases
12/20/2012US20120321746 Proteases
12/20/2012US20120321718 Method of Treating Lactose Intolerance Using Genetically Engineered Bacteria
12/20/2012US20120321700 Compositions And Methods For Inhibiting Expression Of The HAMP Gene
12/20/2012US20120321662 Methods of Eliciting or Boosting a Cellular Immune Response
12/20/2012US20120321661 Recombinant Measles Virus Useful as a Bivalent Vaccine Against Measles and Malarial Infections
12/20/2012US20120321657 Group a streptococcus multivalent vaccine
12/20/2012US20120321655 Lentivirus vaccine based on the recombinant viral vaccine against yellow fever
12/20/2012US20120321654 Infectious clones of torque teno virus
12/20/2012US20120321653 Novel chimeric polynucleotides and polypeptides enabling the secretion of a polypeptide of interest in combination with exosomes and uses thereof
12/20/2012US20120321651 Anti-IGE Vaccines
12/20/2012US20120321649 Peptide Vaccines for Cancers Expressing Tumor-Associated Antigens
12/20/2012US20120321647 Structured rna motifs and compounds and methods for their use
12/20/2012US20120321643 Anti-epidermal growth factor receptor antibodies and uses thereof
12/20/2012US20120321639 Methods and compositions for the inhibition of stat5 in prostate cancer cells
12/20/2012US20120321633 Anti-human epo receptor antibodies and methods of use
12/20/2012US20120321631 Anti-inflammatory agents
12/20/2012US20120321628 Hepatocyte growth factor receptor antagonists and uses thereof
12/20/2012US20120321626 Multi-specific fab fusion proteins and methods of use
12/20/2012US20120321620 Methods and compositions for inhibiting cd32b expressing cells
12/20/2012US20120321619 Anti-c4.4a antibodies and uses thereof
12/20/2012US20120321618 Humanized anti-il 10 antibodies for the treatment of systemic lupus erythematosus (sle)
12/20/2012US20120321617 Humanized anti-il 10 antibodies for the treatment of systemic lupus erythematosus (sle)
12/20/2012US20120321614 Antibodies to c-met
12/20/2012US20120321613 Molecular targets for healing or treating wounds
12/20/2012US20120321608 Detection of mutations in a gene associated with resistance to viral infection, oas1
12/20/2012US20120321607 Factor VII Fusion Polypeptides
12/20/2012US20120321599 Herpes virus strains
12/20/2012US20120321598 Vectors and methods for long-term immune evasion to prolong tranplant viability
12/20/2012US20120321589 Antibody Fusion Proteins with Disrupted Heparin-Binding Activity
12/20/2012US20120321575 Use of kif13a and ap-1 inhibitors for inhibiting melanogenesis
12/20/2012US20120321552 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin
12/20/2012DE112011100641T5 Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung Plants having enhanced yield-related traits and processes for their preparation
12/20/2012DE102011104822A1 Ciliary-Neutrophic-Factor-Varianten Ciliary Neutrophic-factor variants
12/20/2012CA2839530A1 Biomarker compositions and methods
1 ... 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 ... 4023